Consortium
Objectives
Search
Members
National Center for Scientific Research “Demokritos”
Neapoleos & Patriarchou Grigoriou
153 10 Athens
Greece
Homepage
 |
Dr. Alexandra Varvarigou Phone: (+30) 210 650 3683 Fax: (+30) 210 652 2661  Contact |
|
Dr. Penelope Bouziotis Researcher Phone: (+30) 210 650 3683 Fax: (+30) 210 652 2661 Contact |
|
Dr. Eleni Gourni Radiochemist/ Collaborating Scientist Phone: (+30) 210 650 3683 Fax: (+30) 210 652 2661 Contact |
|
Prof. Dr. George Loudos Assistant Professor resposible for imaging equipment Phone: (+30) 6974233203 Fax: (+30) 210 7723557 |
|
Dr. Minas Papadopulous |
|
Prof. Ioannis Kandarakis |
|
Dr. Spyros Archimandritis |
|
Mr. Stavros Xanthopoulos |
|
Mr. Nikolaos Efthimiou |
The Institute of Radioisotopes and Radiodiagnostic Products (I/R-RP) was founded in the 1960s as the sole technology “know-how” source in Greece for the development and production of diagnostic and therapeutic radionuclides, radiopharmaceuticals and radio-immunoassays. Except of serving the needs of the Greek Nuclear Medicine community for almost half a century, the Institute made important steps in order to advance the “know-how” to the state-of-the-art, achieve excellence in research, train graduate students and post-docs and prepare itself managerially for optimum exploitation of the research results. Today, the Institute’s core research activities are in the fields of Biological and Radiopharmaceutical Chemistry, with concurrently running programs in Immuno- and Peptide Chemistry, Protein Chemistry, Pharmaceutical, Bioanalytical and Biophysical Chemistry. The Institute’s first business plan (2001 – 2006) was devised setting goals for interdisciplinary research in scientific areas of important socio-economic impact, that is in Radiopharmacy and Biodiagnostics. Key factors for the success of the business plan have been the rebuilding of the infrastructure to world-class standards, the continuous influx of young researches to the Institute and the strengthening of the Institute’s national and international collaborations.
In 2002, upon recommendation of an International Evaluation Committee, appointed by the Greek General Secretariat of Research and Technology, the Institute was recognized as a National Centre of Excellence in Research in the field of “Functional and Functionalized Biomolecules in Biodiagnosis and Radiopharmacy”. In the summer of 2005 the Institute was re-evaluated by an International Evaluation Committee and, once again, was recognized as having potential for Excellence in Research.
The Institute by tradition maintains close ties with the Greek pharmaceutical industry, leading to a multitude of activities concerning ventures and to collaborations for the exploitation of research results. Two spin-off companies, several privately funded joint ventures, three fully accredited service-providing revenue-producing national-reference labs and a plethora of research agreements with the private sector constitute the achievements for the period leading to 2008.
The Radiopharmacological Studies Group, mainly responsible for the Hellenic part of the Euripides project, is involved for more than ten years with the development and in-vivo evaluation of new radiolabelld diagnostic and therapeutic Biomolecules (monoclonal antibodies, peptides), to be applied in Nuclear Medicine. The study of new radiopharmaceuticals and the training of young scientists are among the most important tasks of the research group.
